As part of a longitudinal investigation of environmental exposures to selected chemical contaminants, concentrations of the pesticide metabolites 1-naphthol (1NAP), 3,5,6-trichloro-2-pyridinol (TCPY), malathion dicarboxylic acid (MDA), and atrazine mercapturate (AM) were measured in repeated samples obtained from 80 individuals in Maryland during 1995±1996. Up to six urine samples were collected from each individual at intervals of approximately 8 weeks over a 1-year period (i.e., one sample per participant in each of six cycles). 1NAP (median=4.2 g/l and 3.3 g/g creatinine) and TCPY (median=5.3 g/l and 4.6. g/g creatinine) were present in over 80% of the samples, while MDA and AM were detected infrequently (6.6% and <1% of samples, respectively). Geometric mean (GM) concentrations of 1NAP in urine did not vary significantly among sampling cycles. In contrast, GM concentrations of TCPY were significantly greater in samples collected during the spring and summer of 1996 than in the preceding fall and winter. Repeated measurements of 1NAP and TCPY from the same individual over time were highly variable. The average range of 1NAP and TCPY concentrations from the same individual were approximately 200% and 50% greater than the respective population mean levels. Geometric mean (GM) TCPY concentrations differed significantly between Caucasian (n=42, GM=5.7 g/g creatinine) and African-American (n=11, GM=4.0 g/g) participants and among education levels, but were not significantly different among groups classified by gender, age, or household income. In future research, environmental measurements of the parent compounds and questionnaire data collected concurrently with the biomarker data will be used to characterize the determinants of variability in the urinary pesticide metabolite levels.
Introduction
Biological markers of exposure to contaminants afford a direct means of assessing the extent of human contact with chemicals in the environment. Biomarkers of exposure are useful in many aspects of environmental health, including analysis of status and trends, epidemiology, and health-risk assessment (Sexton et al., 1995) . Urine is relatively convenient to collect and therefore is a potentially useful medium in which to measure biomarkers of exposure. Urinary concentrations of selected metals, pesticides, and polycyclic aromatic hydrocarbons (PAH) or their metabolites have been used to monitor national trends in exposure in many countries, for example the United States (Kutz et al., 1992; Hill et al., 1995a) and Germany (Trepka et al., 1997) . Biomarkers in urine may be used to assess exposure in environmental epidemiology studies as well (Schulte, 1992) .
Depending on the pharmacokinetics of a compound in the human body, a urinary biomarker may represent shortterm or long-term average exposure. Many organophosphate, carbamate, and triazine pesticides and their metabolites have biological half-lives on the order of days (EPA, 1992) . Thus, urinary biomarkers of exposure to compounds in these pesticide classes are indicative only of recent exposure. If the rate of exposure is relatively constant, a single urinary biomarker measurement may be representative of typical or chronic exposure. The relationship between a single urinary biomarker measurement and chronic exposure to such a pesticide is not well understood. Improved understanding of this relationship is important for investigations of health effects potentially related to chronic pesticide exposure.
In this paper, we report on the relationship between shortterm and long-term average levels of biomarkers of exposure to several pesticides measured in urine samples collected from 80 individuals in greater Maryland. Analyses of variability of exposure levels among and within individuals over time are presented. The implications of our findings with respect to exposure assessment in epidemiology and risk assessment are discussed.
Methods
Eighty individuals randomly selected from five contiguous counties in Maryland were enrolled in the study in September 1995 (Ryan et al., 1999) . Environmental and biological samples, including urine, were collected from participants over a 1-week period during each of six sampling cycles at intervals of approximately 8 weeks over the following 12 months (i.e., in each of six cycles). Sampling cycles 1 through 6 corresponded to September± December 1995 , January±March 1996 , February±April 1996 , April±June 1996 , June±July 1996 , and July±Septem-ber 1996 , respectively. Cycle 1 included a 2-week pilot phase in which samples were collected from nine homes and a 4-week period immediately following that was used to revise standard operating procedures and train new field staff.
Urine samples (first morning void, approximately 250 ml) were collected on the second or eighth day of the week long sampling period in accordance with the respondent's schedule. Urine samples were separated into four fractions for subsequent determination of creatinine, heavy metals (As, Cr), PAH, and pesticide metabolite concentrations. Split urine samples were frozen and shipped on dry ice to the National Center for Environmental Health, Centers for Disease Control and Prevention in Atlanta, Georgia. Concentrations of 1-naphthol (1NAP) and 3,5,6-trichloro-2-pyridinol (TCPY) were determined by GC/ MS/ MS following Hill et al. (1995b) . Atrazine mercapturate (AM) and malathion dicarboxylic acid (MDA) were determined by LC/ MS/ MS (unpublished). The analytical limit of detection (LOD) for each metabolite was 1 g/l.
1NAP is a urinary metabolite of both carbaryl and naphthalene. Carbaryl is a common carbamate insecticide marketed primarily for use on turf and gardens, while naphthalene is used in mothballs and is found in cigarette smoke and petroleum products (Hill et al., 1995a) . TCPY is the major metabolite in urine of the pesticides chlorpyrifos, chlorpyrifos-methyl, and triclopyr and has a biological halflife of approximately 27 h (Bakke et al., 1976; Nolan et al., 1984; Hill et al., 1995a) . TCPY is also the principal product of environmental degradation of chlorpyrifos and may persist in soil for more than 1 year (Racke et al., 1992) . Consequently, urinary levels of TCPY may represent exposure to TCPY as well as its parent compounds. MDA is a principal metabolite of malathion, an organophosphate pesticide used against insects on fruits and vegetables in agriculture and against household insects (EPA, 1992; Kutz et al., 1992) . Malathion has a half-life on the order of days in many environmental media and in animal models, e.g., the rat (EPA, 1992) . AM is a urinary metabolite of atrazine, a widely used herbicide in the United States (EPA, 1992) .
Field blanks and fortified (i.e., spiked) samples were used as quality assurance indicators for sample collection and analysis activities. Field blanks consisted of 18-M water poured from a bulk container to a urine sample cup in the residences of randomly selected participants. Following Shealy et al. (1996) , fortified urine samples containing 1NAP, TCPY, and MDA at 50 g/l and AM at 100 g/l were prepared at the CDC laboratory and transported frozen to the field. Frozen fortified samples were thawed in the field and transferred to a urine sample cup in the residences of randomly selected participants. Thereafter, qualityassurance samples were treated identically to the primary urine samples in all respects.
Descriptive statistics were generated for each pesticide metabolite by cycle, including the number and percentage of samples containing a detectable amount of the analyte, and measures of central tendency and dispersion. Samples containing metabolite concentrations below the LOD were set to 1/2 LOD. Identical data summaries were prepared for creatinine-corrected concentrations expressed in micrograms of metabolite per gram creatinine. These summaries were restricted to urine samples that contained creatinine levels greater than 30 mg/dl as samples with lower creatinine concentrations are generally regarded as too dilute to provide valid results (Lauwerys and Hoet, 1993) .
For 1NAP and TCPY, mixed generalized linear models (GLM) were used to test for significant variability of mean urinary metabolite concentrations among cycles and among individuals. The low number of quantifiable results for AM and MDA prevented statistical analyses of these metabolites from being performed. The repeated measure switch of the SAS procedure PROC MIXED was used to account for potential correlation among metabolite concentrations measured in samples collected from the same individual over time (Littel et al., 1996) . The form of the GLM is shown in Equation 1 where C is the concentration of the pesticide metabolite in urine (g/l), Cycle is a categorical variable with six levels denoting the sampling cycle, and HIN (household identification number) is a categorical variable with a level for each participant. All statistical models were run on natural log-transformed metabolite concentrations to account for skewness in the crude data.
Among respondents that provided a urine sample in at least four cycles, annual average metabolite concentrations were computed as the mean of the results among all cycles. Generalized linear models were used to examine associations between annual average metabolite concentrations and selected demographic factors including gender, age, race, education, and household income. Four levels of age were used: < 25, 25 ±44, 45 ± 64, and greater than 64 years. Education was divided into three categories: at least some high school, high school graduate, and college graduate and above. Four levels of annual household income were used: < $20,000, $20,000 to $< $50,000, $50,000 to < $75,000, and $75,000 or greater.
Results
A total of 376 samples, including 13 field blanks and 13 fortified samples, were collected over the course of the study. All field blanks contained concentrations of the pesticide metabolites below the LOD, except for three that contained 1NAP levels ranging from 2.8 to 53.0 g/l (mean=31.9). Average recovery rates determined from analysis of the fortified samples were 95% for TCPY (range 82±104%), 104% for 1NAP (94 ±120), 119% for MDA (94 ± 136), and 93% for AM (84 ±100). Field blank results and recovery rates did not vary systematically among cycles or field technicians. Tables 1 and 2 summarize the results of the analyses of 1NAP, TCPY, AM, and MDA concentrations in urine samples obtained from the study participants. These results are unweighted such that the sample is the unit of observation. In Table 1 , concentrations are expressed as micrograms of metabolite per liter of urine. Of the 350 urine samples collected and analyzed, 27 (7.7%) had missing data for creatinine or at least one residue. Reasons for missing data included insufficient specimen volume and analytical problems such as matrix interference. 1NAP and TCPY were present at detectable levels in the majority of the samples, while AM and MDA were detected infrequently. In Table 2 , the summary statistics are presented in terms of micrograms of metabolite per gram of creatinine.
The arithmetic mean 1NAP concentrations reported in Tables 1 and 2 are strongly influenced by results from one participant. 1NAP concentrations for this participant ranged from 540 to 2500 g /l with a mean of 1396 g/ l. This individual had the five highest creatinine-corrected 1NAP concentrations, 860, 1600, 2600, 3000, and 4600 g/g and an arithmetic mean concentration approximately ten times greater than that for any other participant. Seven other samples, obtained from five participants, had creatininecorrected concentrations greater than 100 g /g. On questionnaires administered in each sampling cycle this participant did not report smoking tobacco, use of carbaryl at work or at home, use of mothballs (some of which use naphthalene as the active ingredient) at home, or exposure to environmental tobacco smoke, all potential sources of exposure to compounds degraded to 1NAP in humans.
Although potentially a true outlier, we chose to retain this individual in the data set and to explore the influence of their inclusion on subsequent data summaries and analyses.
Removal of this participant from the data set yielded a mean 1NAP concentration of 13.2 g/l and a mean creatininecorrected concentration of 13.0 g/g.
Results by Cycle
The number of urine samples collected in cycles 1±6 was 57, 59, 67, 60, 50, and 58, respectively. The frequency of detection of the four pesticide metabolites in urine by cycle is presented in Table 3 . The detection rate for 1NAP ranged from 78% in cycles 5 and 6 to 86% in cycle 2. TCPY was detected in the urine from at least 95% of the respondents in all cycles except cycle 2 where the detection rate was 83%. The lone sample that contained a detectable concentration of AM was collected in cycle 2, while the detection rate for MDA peaked at 13% during cycle 5. The distribution of 1NAP and TCPY concentrations by cycle are summarized graphically in Figures 1 and 2 . Arithmetic mean cycle-specific 1NAP concentrations ranged from 14.9 g/l in cycle 1 to 88.8 in cycle 3. In contrast, the median 1NAP concentration ranged from only 2.7 to 4.1 g/l among cycles. Similarly, the interquartile range for 1NAP exhibited a relatively small range among cycles (5.3 to 10.3 g/ l) compared to variability of the arithmetic mean. The arithmetic mean TCPY concentration in each cycle was approximately 6 g /l and ranged from 4.2 g /l in cycle 2, to 6.8 g/ l in cycle 4. 
Results by Participant
At least one urine sample from all 80 participants was collected and analyzed for the selected pesticide metabolites over the course of the 1-year study. The number of participants from which a given number (i.e., 1 to 6) of valid 1NAP and TCPY results were obtained is summarized in Table 4 . 1NAP and TCPY results from at least four cycles were obtained from 53 of the participants. The average intra-individual range of 1NAP concentrations was 108 g/g, while that for TCPY was 7.0 g/g. Removing the potential outlier from the 1NAP data set reduced the average within-individual range to 38.1 g/g. Among these participants, the arithmetic mean annual average creatinine-corrected 1NAP and TCPY concentrations were 62.2 g /g (14.7 g /g when omitting the potential outlier) and 5.9 g /g (2.3 to 13.1), respectively. Cumulative distribution functions for average annual creatinine-corrected 1NAP and TCPY concentrations are plotted in Figure 3 .
Temporal and Population Variability
Geometric mean creatinine-corrected urinary concentrations of 1NAP did not vary significantly among cycles ( p =0.3897), however, they were significantly different among individuals ( p<0.0001). Omitting the potential outlier from the data set did not change the outcome of the repeated measures GLM with respect to the statistical significance of sampling cycle or participant effects on creatinine-corrected 1NAP concentrations. For TCPY, mean concentrations were found to vary significantly ( p<0.0001) among cycles and among individuals.
Demographic Covariates
The geometric means for creatinine-corrected annual average 1NAP and TCPY concentrations by selected demographic factors are shown in Figures 4 and 5 . Geometric mean 1NAP concentrations did not differ significantly between genders ( p =0.929), between races ( p =0.9706), among education groups ( p =0.1426), or among groups of annual household income ( p =0.3978). Geometric mean 1NAP concentrations varied significantly ( p =0.0141) among age groups with levels in the two older age groups greater than those in the two younger ones. Omission of data for the potential 1NAP outlier caused differences among age groups to no longer be significant ( p =0.1005), but did not substantially affect the conclusions of the other analyses. For TCPY, geometric mean concentrations were found to differ significantly ( p =0.0260) between races and among the three education groups ( p =0.0127). Differences in TCPY concentrations were not significantly different between genders ( p =0.8191), among age groups (0.7524), or among income groups ( p =0.5771).
Discussion
In this study, urine samples were collected from up to 80 individuals at up to six different times or cycles approximately equally spaced over 1 year. The concentrations of 1NAP, TCPY, and MDA measured in these samples, representing exposure to naphthalene or carbaryl; chlorpyrifos, chlorpyrifos-methyl or triclopyr; and malathion, respectively, were similar to those found in previous investigations . Concentrations of AM in urine, representative of exposure to atrazine, to our knowledge have not been published elsewhere, thereby precluding direct comparison of our results with those from other studies. Among urine samples collected from approximately 1000 adult participants between 1988 and 1994 in the National Health and Nutrition Examination Survey III (NHANES III), 1NAP was detected at a rate of 86% and the mean creatinine-corrected concentration was 17 g/g (Hill et al., 1995a,b) . The frequency of 1NAP detection was nearly equal to that in the present study (Table 1) , as was the central tendency, when results from the potential outlier in our population were omitted, and the distribution of concentrations. The maximum 1NAP concentration measured in the NHANES III population was 2500 g/l Figure 5 . Geometric mean creatinine-corrected 3,5,6-trichloro-2-pyridinol concentrations by selected demographic factors. Error bars denote one standard error. Sample size for each group is shown in parentheses along x-axis.
(1400 g/g creatinine), suggesting that the upper-end extreme values in our data set represent true, albeit high, measures rather than sampling or analysis artifacts.
TCPY was found in 82% of the NHANES III urine samples and 5.8% of the NHANES II urines collected between 1976 ±1980 (Kutz et al., 1992; Hill et al., 1995a,b) . In our study, conducted from 1995 ±1996, TCPY was present at measurable levels in 96% of the samples, indicating that frequency of exposure to chlorpyrifos, chlorpyrifos-methyl, triclopyr, or TCPY in the NHEXASMaryland study population was similar to that observed in the most recent national survey. Mean and median creatinine-corrected TCPY concentrations measured in the present study (5.8 and 4.6 g/g, respectively) are approximately twofold greater than those measured in NHANES III (3.1 and 2.2 g /g, respectively), however, the upper end of the distributions are approximately equal.
Less than 1% of the urine samples from the NHANES II population were found to contain detectable concentrations of MDA in urine, compared to 6.6% in the Maryland study population (Kutz et al., 1992) . Despite the higher frequency of detection in the present study, the maximum NHANES II concentration of 250 g /l exceeded that observed here by a factor of 5 (Table 1) .
As noted earlier, biomarkers of exposure can be used to document status and trends of exposure within populations or population subgroups and as inputs to epidemiological investigations of health effects of chemical exposure and human health risk assessments. The repeated measures feature of the NHEXAS-Maryland study design affords a relatively unique ability to investigate temporal variability of exposure to selected chemicals and the implications with respect to potential uses of exposure data.
We found that log-transformed population mean 1NAP concentrations in urine did not vary significantly among six sampling periods spaced over a year. This result indicates that the timing of sample collection may not be an important design consideration for studies (e.g., status and trend analyses and chronic risk assessments) that intend to utilize the population geometric mean concentration of this compound. Because the distribution of 1NAP concentrations did not vary substantially among sampling cycles, assessments of risk related to acute exposures to naphthalene/carbaryl may also be insensitive to the time of year in which exposure input data are obtained.
Mean log-transformed, creatinine-corrected TCPY concentrations in urine were found to vary significantly among cycles. Median levels differed by nearly a factor of 2 between cycles 2 and 6 with an apparent shift toward higher levels in the spring, summer and early autumn. With respect to chlorpyrifos, this shift may reflect increased rates of residential application for insect control during the warmer months of the year or greater application to agricultural commodities during the growing season. The shift may also reflect application of the herbicide triclopyr during the growing season. While statistically significant, variability of median TCPY concentrations among cycles may not be substantive in the context of some environmental health applications. For example, other errors in health risk assessments (e.g., the dose ± response curve) may be much larger. However, if mean or median TCPY concentrations for a population vary systematically by season, then timing of sample collection should be an explicit component of longitudinal studies designed to characterize status and trends of TCPY levels in urine.
The typical range of intra-individual variability of 1NAP and TCPY concentrations in the NHEXAS-Maryland population was greater than the corresponding population mean and median concentrations. The average range of 1NAP measurements from a single participant was approximately two times greater than the population mean level and approximately six times greater than the median concentration for the population. For TCPY, the average range of measurements from a single respondent was approximately 50% greater than both the population mean and median concentration. In epidemiology, the objective of exposure assessment often is to place an individual into a broad category of exposure relative to other individuals in the study (e.g., the upper or lower quintile). Our results indicate that a single measure of urinary 1NAP and TCPY levels is not sufficient to characterize accurately the relative magnitude of a person's typical acute or chronic exposure to the respective parent compounds. Use of these results to determine the minimum number of 1NAP and TCPY results from an individual required to achieve a specified degree of misclassification error will be a component of future research.
In this paper, we reported on the occurrence of urinary metabolites indicative of exposure to naphthalene or carbaryl; chlorpyrifos, chlorpyrifos-methyl, or triclopyr; malathion, and atrazine in repeated samples obtained from a probability sample drawn from Maryland. 1NAP and TCPY were present in over 80% of the samples, while MDA and AM were detected infrequently. Mean and median concentrations of 1NAP and TCPY in urine did not vary substantially among sampling cycles, while repeated measurements from the same individual over time were highly variable. In future research, environmental measurements of the parent compounds and questionnaire data collected concurrently with the biomarker data will be used to characterize the determinants of variability in the urinary pesticide metabolite levels.
